Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-53-6
Name of the chemical
Distillates (petroleum), hydrotreated light naphthenic
Concentration
35-40
EC/CAS
64742-46-7
Name of the chemical
Distillates (petroleum), hydrotreated middle
Concentration
40-45 1-5
General Information
Revision date
2003-05-01
Product name
BRAYCO MICRONIC 762
supplier name
Air BP Lubricants
Manufacturer Name
Air BP Lubricants
Icons in SDS
Company Information
company name
Product Stewardship
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Physical state / Liquid. Appearance Solvent. Odor Clear. Yellow. Liquid. Emergency Overview WARNING!
Aspiration hazard
CAUSES EYE AND SKIN IRRITATION. MAY CAUSE RESPIRATORY TRACT IRRITATION. if swallowed -- harmful or fatal if liquid is aspirated into lungs. Do not ingest. If ingested do not induce vomiting. Keep container closed. Wash thoroughly after handling. Avoid contact with skin and eyes. However, in light of good industrial hygiene, exposure to any chemical should be kept to a minimum. Keep away from heat, sparks and flame. Routes of Entry Skin Contact. Eye contact. Inhalation. Ingestion. if swallowed- can enter lungs and cause damage Oral LD50: Not established. Ingestion may cause gastrointestinal irritation and diarrhea. No additional remark.
Potential Acute Health Effects
Eyes Causes eye irritation. Skin Causes skin irritation. Inhalation Vapor: Solution may cause irritation of mouth, throat, and esophagus. High vapor concentrations can cause headaches, dizziness, drowsiness, and nausea, and may lead to unconsciousness. Vapor: Prolonged repeated exposure may cause chemical pneumontitis. Ingestion
Potential chronic health
Prolonged or repeated contact can defat the skin and lead to irritation and/or dermatitis. Effects CARCINOGENIC EFFECTS: No component of this product at levels greater than 0.1% is identified as a carcinogen by ACGIH or the International Agency for Research on Cancer (IARC). No component of this product present at levels greater than 0.1% is identified as a carcinogen by the U.S. National Toxicology Program (NTP) or the U.S. Occupational Safety and Health Act (OSHA). MUTAGENIC EFFECTS: No component of this product at levels greater than 0.1% is classified by established regulatory criteria as a mutagen.
Teratogenic Effects
No component of this product at levels greater than 0.1% is classified by established regulatory criteria as teratogenic or embryotoxic. Medical Conditions Repeated or prolonged exposure is not known to aggravate medical condition. Aggravated by Overexposure: Overexposure Not available. /Signs/Symptoms See Toxicological Information (section 11)
